Jadenu Sprinkle

Indicated For

iron overload, pediatric

About This Medication

# Novartis Patient Assistance Foundation Patient Guide: How to Get Jadenu Sprinkle at Low or No Cost Jadenu Sprinkle (deferasirox) is an oral granule medication used to treat chronic iron overload due to blood transfusions in patients with conditions like thalassemia or myelodysplastic syndromes. The **Novartis Patient Assistance Foundation (NPAF)** offers this medication at no cost to eligible patients who meet specific income, residency, and insurance criteria.[1][2][3] ## About Jadenu Sprinkle **Jadenu Sprinkle** contains deferasirox, an iron chelator that binds to excess iron in the body and helps remove it through urine. It's particularly useful for patients who can't swallow tablets, as the granules can be mixed with soft food like applesauce or yogurt. Always take it as prescribed by your doctor, typically once daily on an empty stomach or with a light meal. Common side effects include nausea, vomiting, diarrhea, and kidney or liver issues—report any unusual symptoms to your healthcare provider immediately. This program helps ensure access for those facing high costs.[1][2] ## Who Qualifies for the Program? To qualify for free **Jadenu Sprinkle** through NPAF, you must: - Reside in the United States or a U.S. territory. - Have limited or no prescription insurance coverage (details below). - Meet income guidelines based on household size and federal poverty level (FPL). - Have a valid prescription from a licensed U.S. healthcare provider for outpatient treatment.[2][3][5] The program is designed for patients struggling with out-of-pocket costs, providing medication shipped directly to your home at no charge if approved.[3] ## Income Eligibility Breakdown Income limits vary by Novartis product, household size, and insurance status. For many medications like Jadenu Sprinkle, eligibility is up to **400% of the Federal Poverty Level (FPL)**. Insured patients (except Medicare) must also show out-of-pocket costs are at least **8% of annual household income**. Submit the first two pages of your most recent tax return (Form 1040) as proof.[1][5] Here's a breakdown based on 2026 FPL guidelines (approximate; check www.PAP.Novartis.com for exact figures per household size): | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 (Individual) | $60,000 | | 2 (Couple) | $81,000 | | 3 | $102,000 | | 4 | $123,000 | | 5 | $144,000 | **Notes**: Limits provided are illustrative; actual thresholds for Jadenu Sprinkle may differ and can reach up to $187,200 for individuals in some cases. Household size is based on your tax return. If not required to file taxes, contact NPAF. Varying product-specific rules apply—verify eligibility online first.[1][5] ## Insurance Requirements NPAF requires **no private or public prescription coverage**. Exceptions exist for Medicare Part D or B patients if cost-sharing is unaffordable (provide proof). Submit front/back copies of all insurance cards, including primary, secondary, and prescription coverage. If insured, include prior authorization (PA) or appeal denials. Patients with active coverage are typically ineligible unless it meets the unaffordable threshold.[1][2][5] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit www.PAP.Novartis.com to confirm Jadenu Sprinkle qualifies and review your income/insurance fit.[2][3] 2. **Gather Documents**: Collect proof of income (first 2 pages of tax return or alternatives like W-2s, pay stubs, 1099s), insurance cards (front/back), and Extra Help denial if applicable.[1][5][7] 3. **Complete the Application**: Download from www.PAP.Novartis.com. Fill out patient section (personal info, income, household size, authorization). Your doctor completes the prescriber section, including prescription and medical details.[2][4] 4. **Sign and Date**: Patient and doctor must sign. Incomplete forms cause delays or denials.[1][2] 5. **Submit**: Fax to 1-855-817-2711 or mail to Novartis Patient Assistance Foundation, PO Box 2529, Columbus, OH 43216. Multiple methods available; phone support at (888) 903-7277 or 1-800-277-2254 (Mon-Fri, 9am-6pm EST).[1][3][5] ## Timeline and Delivery Expect a decision within **4 weeks** of submission. If incomplete, you'll get a letter or text with next steps. Approved medication is **shipped free to your home**. Track status by calling NPAF.[3][5] ## Reauthorization and Refills **Reauthorization is required** annually or as specified. Submit updated income proof and doctor confirmation before supply ends to avoid gaps.[9] ## Alternatives if Denied If denied, the outcome letter explains why (e.g., income too high, insurance issues). Options include: - Appeal with additional documents. - Apply for state assistance, Extra Help (Medicare), or other PAPs. - Explore Novartis co-pay programs if insured (not NPAF). - Contact NPAF at 1-800-277-2254 for guidance. No biosimilar alternatives listed for deferasirox.[3][6] ## Important Disclaimer This guide is for informational purposes only and based on available program details as of 2026. Eligibility, income limits, and processes can change—always verify at www.PAP.Novartis.com or by calling NPAF. Not medical advice; consult your doctor for treatment. Novartis or NPAF may update terms. Assistance not guaranteed; complete applications required. Word count: 1028.

Program information last verified: March 30, 2026